These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28144040

  • 1. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
    Szűcs Z, Bereczki I, Csávás M, Rőth E, Borbás A, Batta G, Ostorházi E, Szatmári R, Herczegh P.
    J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the Velogene genomic assay for detection of vanA and vanB genes in vancomycin-resistant Enterococcus species.
    Appleman MD, Citron DM, Kwok R.
    J Clin Microbiol; 2004 Apr; 42(4):1751-2. PubMed ID: 15071039
    [Abstract] [Full Text] [Related]

  • 3. Emergence of vanA Genotype Vancomycin-Resistant Enterococci with Low or Moderate Levels of Teicoplanin Resistance in Korea.
    Eom JS, Hwang IS, Hwang BY, Lee JG, Lee YJ, Cheong HJ, Park YH, Park SC, Kim WJ.
    J Clin Microbiol; 2004 Apr; 42(4):1785-6. PubMed ID: 15071050
    [Abstract] [Full Text] [Related]

  • 4. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [Abstract] [Full Text] [Related]

  • 5. Rapid detection and differentiation method of VanA, VanB and VanC phenotypes in vancomycin-resistant enterococci.
    Hanaki H, Yamaguchi Y, Nomura S, Nagayama A, Sunakawa K.
    Int J Antimicrob Agents; 2004 May; 23(5):502-5. PubMed ID: 15120731
    [Abstract] [Full Text] [Related]

  • 6. New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
    Malabarba A, Ciabatti R, Scotti R, Goldstein BP, Ferrari P, Kurz M, Andreini BP, Denaro M.
    J Antibiot (Tokyo); 1995 Aug; 48(8):869-83. PubMed ID: 7592033
    [Abstract] [Full Text] [Related]

  • 7. Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin.
    Hill CM, Krause KM, Lewis SR, Blais J, Benton BM, Mammen M, Humphrey PP, Kinana A, Janc JW.
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2814-8. PubMed ID: 20404117
    [Abstract] [Full Text] [Related]

  • 8. vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters.
    Nakipoğlu M, Yilmaz F, Icgen B.
    Bull Environ Contam Toxicol; 2017 May; 98(5):712-719. PubMed ID: 27770152
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N, Goessens W, van Belkum A, Verbrugh HA, Endtz HP.
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [Abstract] [Full Text] [Related]

  • 10. [Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates].
    Coşkun FA, Mumcuoğlu I, Aksu N, Karahan ZC, Us E, Tekeli FA, Baran I, Kanyılmaz D, Kurşun S.
    Mikrobiyol Bul; 2012 Apr; 46(2):276-82. PubMed ID: 22639316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
    Song JH, Ko KS, Suh JY, Oh WS, Kang CI, Chung DR, Peck KR, Lee NY, Lee WG.
    J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
    [Abstract] [Full Text] [Related]

  • 16. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance.
    Hashimoto Y, Tanimoto K, Ozawa Y, Murata T, Ike Y.
    FEMS Microbiol Lett; 2000 Apr 15; 185(2):247-54. PubMed ID: 10754256
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
    Kolár M, Vágnerová I, Látal T, Kohnová I.
    Acta Univ Palacki Olomuc Fac Med; 1999 Apr 15; 142():69-71. PubMed ID: 10743728
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.
    Szűcs Z, Csávás M, Rőth E, Borbás A, Batta G, Perret F, Ostorházi E, Szatmári R, Vanderlinden E, Naesens L, Herczegh P.
    J Antibiot (Tokyo); 2017 Feb 15; 70(2):152-157. PubMed ID: 27353163
    [Abstract] [Full Text] [Related]

  • 19. Glycopeptide-resistance transferability from vancomycin-resistant enterococci of human and animal source to Listeria spp.
    de Niederhäusern S, Sabia C, Messi P, Guerrieri E, Manicardi G, Bondi M.
    Lett Appl Microbiol; 2004 Feb 15; 39(6):483-9. PubMed ID: 15548299
    [Abstract] [Full Text] [Related]

  • 20. Vancomycin-susceptible dairy and clinical enterococcal isolates carry vanA and vanB genes.
    Ribeiro T, Abrantes M, Lopes Mde F, Crespo MT.
    Int J Food Microbiol; 2007 Feb 15; 113(3):289-95. PubMed ID: 17140688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.